Besides, CD44 was positively associated with several metabolic pathways, including glycogen biosynthesis, galactose metabolism, glycosaminoglycan biosynthesis, N-glycan biosynthesis, and starch and suctose metabolism (Figure 2B), indicating a highly activated tumor microenvironment. This evidence concerns the gene CD44 and neoplasm.